Tepmetko 225mg Tablet
Prescription Required
Product introduction
Tepmetko 225mg Tablet is used to treat advanced non-small cell lung cancer in adult patients. It is used in patients in whom the cancer has either spread to other parts of the body or cannot be removed by surgery and previous treatment has not helped to stop the cancer.
Tepmetko 225mg Tablet helps by slowing or stopping the cancer from growing. Tepmetko 225mg Tablet should be taken with food and swallowed as a whole. Do not crush or chew the tablet. The dose and duration of the treatment will depend on your condition and how well you respond to it. However, take it for as long as your doctor has prescribed. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless the doctor tells you to.
The most common side effects of Tepmetko 225mg Tablet include peripheral edema, nausea, hypoalbuminemia, diarrhea, and an increase in creatinine. If any of these side effects bother you, let your doctor know. They may also advise regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect or be affected by this medicine, so let your doctor know about all the other medicines that you are using. Tepmetko 225mg Tablet is not recommended during pregnancy or while breastfeeding. Hence, it is important for both males and females of reproductive age to use effective contraception to avoid pregnancy during the treatment with this medicine.
Tepmetko 225mg Tablet helps by slowing or stopping the cancer from growing. Tepmetko 225mg Tablet should be taken with food and swallowed as a whole. Do not crush or chew the tablet. The dose and duration of the treatment will depend on your condition and how well you respond to it. However, take it for as long as your doctor has prescribed. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless the doctor tells you to.
The most common side effects of Tepmetko 225mg Tablet include peripheral edema, nausea, hypoalbuminemia, diarrhea, and an increase in creatinine. If any of these side effects bother you, let your doctor know. They may also advise regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect or be affected by this medicine, so let your doctor know about all the other medicines that you are using. Tepmetko 225mg Tablet is not recommended during pregnancy or while breastfeeding. Hence, it is important for both males and females of reproductive age to use effective contraception to avoid pregnancy during the treatment with this medicine.
Uses of Tepmetko Tablet
Benefits of Tepmetko Tablet
In Treatment of Non-small cell lung cancer
Tepmetko 225mg Tablet is used to treat a certain type of non-small cell lung cancer that has spread to other body parts in adults.
Side effects of Tepmetko Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Tepmetko
- Peripheral edema
- Nausea
- Low albumin level in blood
- Diarrhea
- Increased creatinine level in blood
How to use Tepmetko Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tepmetko 225mg Tablet is to be taken with food.
How Tepmetko Tablet works
Tepmetko 225mg Tablet works by blocking the action of certain abnormal proteins that signal cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Tepmetko 225mg Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Tepmetko 225mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CAUTION
Tepmetko 225mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
SAFE
Tepmetko 225mg Tablet does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Tepmetko 225mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Tepmetko 225mg Tablet is recommended.
Liver
SAFE IF PRESCRIBED
Tepmetko 225mg Tablet is safe to use in patients with liver disease. No dose adjustment of Tepmetko 225mg Tablet is recommended.
What if you forget to take Tepmetko Tablet?
If you miss a dose of Tepmetko 225mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Women of childbearing potential should use effective contraception during the treatment and for at least 1 week after the last dose of Tepmetko 225mg Tablet.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor and eat small, frequent meals.
- Swelling of the hands or feet is a common side effect of Tepmetko 225mg Tablet. Your doctor may suggest leg elevation or dietary salt modification to ease the symptoms of swelling.
- Drink at least 7-8 large glasses of water every 24 hours, unless you are instructed otherwise.
Fact Box
Chemical Class
Cytochrome P-450 Inhibitors
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- DrugBank. Tepotinib. [Accessed 15 Mar. 2023]. (online) Available from:
- Tepotinib [Summary of Product Characteristics]. Amsterdam, The Netherlands: Merck Europe B.V. [Accessed 15 Mar. 2023]. (online) Available from:
Marketer details
Name: Merck Ltd
Address: L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India
Country of origin: Germany
Lab tests offered by us
Related/Popular tests
₹146563
Inclusive of all taxes
MRP₹152829 4% OFF
30.0 tablets in 1 box
SOLD OUT
Notify me
